LATEST UPDATES

2 persons impersonating as IPS officer, Inspector arrested in Jammu

Precious Kashmir 03/10/2023

No terrorism in Srinagar; district peaceful: IG CRPF

Precious Kashmir 03/10/2023

India asks Canada to withdraw 40 diplomats by Oct 10: Reports

Indo Asian News Service 03/10/2023

Delhi Police raid journalists linked to NewsClick amid China funding allegations

Indo Asian News Service 03/10/2023

Rajouri encounter: Two soldiers injured in exchange of fire

Precious Kashmir 03/10/2023

DHSK holds Ayushman Buva sabhas across health institutions in Kashmir

Precious Kashmir 02/10/2023

J&K Govt orders suspension of DySP, Additional SP

Precious Kashmir 01/10/2023

All officers, staff of Hazratbal shrine suspended for negligence of duties

Precious Kashmir 01/10/2023

Narcotics worth Rs 100 crore seized in Ramban, 2 arrested: Police

Precious Kashmir 01/10/2023

School timings in Srinagar to change from  October 1

Precious Kashmir 30/09/2023

Law panel recommends formation of national portal for registration of e-FIR

Precious Kashmir 30/09/2023

2 arrested for duping people on pretext of resolving credit card issues

Indo Asian News Service 30/09/2023
  • Home
  • Front
  • Jammu & Kashmir
    • City
  • Anchor stories
  • Business
  • Sports
  • National
  • World
  • Opinion
    • Edit
    • Interviews
    • Letters
  • Epaper
  • Video
Wednesday, October 4, 2023
PRECIOUS KASHMIR
No Result
View All Result
  • Home
  • Front
  • Jammu & Kashmir
    • City
  • Anchor stories
  • Business
  • Sports
  • National
  • World
  • Opinion
    • Edit
    • Interviews
    • Letters
  • Epaper
  • Video
Precious Kashmir
No Result
View All Result
Home Health

US scientists’ cancer-killing pill can ‘annihilate all solid tumours’

Indo Asian News Service by Indo Asian News Service
03/08/2023
in Health
2 min read
Site-specific drug delivery for cancer management and treatment
FacebookTwitterWhatsappEmail

New York: A team of US scientists have, in a major breakthrough, developed a novel cancer-stopping pill that can annihilate all solid tumours.

The pill, named AOH1996, has shown to be effective in pre-clinical research treating cells derived from breast, prostate, brain, ovarian, cervical, skin, and lung cancers.

Developed by a team at City of Hope in California, US, AOH1996 was named after Anna Olivia Healy, who was born in 1996 and died when she was just nine-years-old after being diagnosed with a rare childhood cancer neuroblastoma.

According to Linda Malkas, Professor in City of Hope’s Department of Molecular Diagnostics and Experimental Therapeutics, most targeted therapies focus on a single pathway, which enables wily cancer to mutate and eventually become resistant.

However, the cancer-killing pill that Malkas has been developing over the past two decades, attacks a protein called proliferating cell nuclear antigen (PCNA), which encourages tumours to grow by aiding DNA replication and the repair of cancerous cells.

“PCNA is like a major airline terminal hub containing multiple plane gates. Data suggests PCNA is uniquely altered in cancer cells, and this fact allowed us to design a drug that targeted only the form of PCNA in cancer cells.

“Our cancer-killing pill is like a snowstorm that closes a key airline hub, shutting down all flights in and out only in planes carrying cancer cells,” said Malkas, who published the findings in the journal Cell Chemical Biology.

Malkas noted that results in cell and animal models have been promising and Phase 1 clinical trial in humans is currently underway. “AOH1996 can suppress tumour growth as a monotherapy or combination treatment in cell and animal models without resulting in toxicity”.

The researchers tested AOH1996, a small molecule PCNA inhibitor, in more than 70 cancer cell lines and several normal control cells. They found that AOH1996 selectively kills cancer cells by disrupting the normal cell reproductive cycle. It targets something called transcription replication conflicts, which occur when mechanisms responsible for gene expression and genome duplication collide.

The investigational therapy prevented cells with damaged DNA from dividing in G2/M phase and from making a copy of faulty DNA in S phase. As a result, AOH1996 caused cancer cell death (apoptosis), but it did not interrupt the reproductive cycle of healthy stem cells.

“No one has ever targeted PCNA as a therapeutic because it was viewed as ‘undruggable,’ but clearly City of Hope was able to develop an investigational medicine for a challenging protein target,” said lead author Long Gu, Associate research Professor in the Department of Molecular Diagnostics and Experimental Therapeutics at Beckman Research Institute of City of Hope.

“We discovered that PCNA is one of the potential causes of increased nucleic acid replication errors in cancer cells. Now that we know the problem area and can inhibit it, we will dig deeper to understand the process to develop more personalised, targeted cancer medicines,” Long said.

Interestingly, experiments showed that the investigational pill made cancer cells more susceptible to chemical agents that cause DNA or chromosome damage, such as the chemotherapy drug cisplatin, hinting that AOH1996 could become a useful tool in combination therapies as well as for the development of new chemotherapeutics.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to print (Opens in new window)

Related

Share196Tweet123SendSend
Indo Asian News Service

Indo Asian News Service

ePAPER

Precious Kashmir

Copyright © 2020 Precious Kashmir.

Navigate Site

  • Home
  • About Us
  • Contact Us
  • Advertise with Us
  • Terms of Service

Follow Us

No Result
View All Result
  • Home
  • Front
  • Jammu & Kashmir
    • City
  • Anchor stories
  • Business
  • Sports
  • National
  • World
  • Opinion
    • Edit
    • Interviews
    • Letters
  • Epaper
  • Video

Copyright © 2020 Precious Kashmir.